Contemporary risk models for infective endocarditis surgery: a narrative review.

IF 2.6 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Ankit Agrawal, Aro Daniela Arockiam, Yasser Jamil, Joseph El Dahdah, Bianca Honnekeri, Michel Chedid El Helou, Joseph Kassab, Tom Kai Ming Wang
{"title":"Contemporary risk models for infective endocarditis surgery: a narrative review.","authors":"Ankit Agrawal,&nbsp;Aro Daniela Arockiam,&nbsp;Yasser Jamil,&nbsp;Joseph El Dahdah,&nbsp;Bianca Honnekeri,&nbsp;Michel Chedid El Helou,&nbsp;Joseph Kassab,&nbsp;Tom Kai Ming Wang","doi":"10.1177/17539447231193291","DOIUrl":null,"url":null,"abstract":"<p><p>Infective endocarditis is a complex heterogeneous condition involving the infection of the endocardium and heart valves, leading to severe complications, including death. Surgery is often indicated in patients with infective endocarditis but is associated with elevated risk compared with other forms of cardiac surgery. Risk models play an important role in many cardiac surgeries as they can help inform clinicians and patients regarding procedural risk, decision-making to proceed or not, and influence perioperative management; however, they remain under-utilized in the infective endocarditis settings. Another crucial role of such risk models is to assess predicted <i>versus</i> found mortality, thereby allowing an assessment of institutional performance in infective endocarditis surgery. Traditionally, general cardiac surgery risk models such as European System for Cardiac Operative Risk Evaluation (EuroSCORE), EuroSCORE II, and Society of Thoracic Surgeon's score have been applied to endocarditis surgery. However, there has been the development of many endocarditis surgery-specific scores over the last decade. This review aims to discuss clinical characteristics and applications of all contemporary risk scores in the setting of surgical treatment of infective endocarditis.</p>","PeriodicalId":23035,"journal":{"name":"Therapeutic Advances in Cardiovascular Disease","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/86/10.1177_17539447231193291.PMC10469256.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Cardiovascular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17539447231193291","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Infective endocarditis is a complex heterogeneous condition involving the infection of the endocardium and heart valves, leading to severe complications, including death. Surgery is often indicated in patients with infective endocarditis but is associated with elevated risk compared with other forms of cardiac surgery. Risk models play an important role in many cardiac surgeries as they can help inform clinicians and patients regarding procedural risk, decision-making to proceed or not, and influence perioperative management; however, they remain under-utilized in the infective endocarditis settings. Another crucial role of such risk models is to assess predicted versus found mortality, thereby allowing an assessment of institutional performance in infective endocarditis surgery. Traditionally, general cardiac surgery risk models such as European System for Cardiac Operative Risk Evaluation (EuroSCORE), EuroSCORE II, and Society of Thoracic Surgeon's score have been applied to endocarditis surgery. However, there has been the development of many endocarditis surgery-specific scores over the last decade. This review aims to discuss clinical characteristics and applications of all contemporary risk scores in the setting of surgical treatment of infective endocarditis.

Abstract Image

Abstract Image

Abstract Image

感染性心内膜炎手术的现代风险模型:叙述性综述。
感染性心内膜炎是一种复杂的异质性疾病,涉及心内膜和心脏瓣膜的感染,导致严重并发症,包括死亡。手术通常适用于感染性心内膜炎患者,但与其他形式的心脏手术相比,手术风险较高。风险模型在许多心脏手术中发挥着重要作用,因为它们可以帮助临床医生和患者了解手术风险、是否进行决策,并影响围手术期管理;然而,它们在感染性心内膜炎中的应用仍然不足。这种风险模型的另一个关键作用是评估预测死亡率与发现死亡率,从而评估机构在感染性心内膜炎手术中的表现。传统上,一般心脏手术风险模型,如欧洲心脏手术风险评估系统(EuroSCORE)、EuroSCORE II和胸科医生协会评分,已应用于心内膜炎手术。然而,在过去的十年里,已经有了许多心内膜炎手术特异性评分的发展。本综述旨在讨论感染性心内膜炎外科治疗的临床特点和所有当代风险评分的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Cardiovascular Disease
Therapeutic Advances in Cardiovascular Disease CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.50
自引率
0.00%
发文量
11
审稿时长
9 weeks
期刊介绍: The journal is aimed at clinicians and researchers from the cardiovascular disease field and will be a forum for all views and reviews relating to this discipline.Topics covered will include: ·arteriosclerosis ·cardiomyopathies ·coronary artery disease ·diabetes ·heart failure ·hypertension ·metabolic syndrome ·obesity ·peripheral arterial disease ·stroke ·arrhythmias ·genetics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信